In this CE activity, experts in the field review the latest imaging tools for the early diagnosis and monitoring of disease progression; evaluate clinical and imaging characteristics associated with disease progression in different phenotypes; and assess individualized treatment selection for patients with GA secondary to AMD
- Provider:Vindico Medical Education, LLC
- Activity Link: https://www.healio.com/cme/mededtalks/ophthalmology/20241202/ga-secondary-to-amd-optimizing-long-term-outcomes-through-refined-treatment-selection/overview
- Start Date: 2024-12-05 06:00:00
- End Date: 2024-12-05 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: Source: Apellis Pharmaceuticals, Inc. - Amount: 27813.33 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest